This website uses cookies. By continuing to browse this website you are agreeing to our use of cookies. Find out more by reading our privacy policy. Read more
Scientific publications
Scientific articles authored by Novo Nordisk
The information you can search here is retrieved via the database Current Contents®, covering 95% of publications within the life science area. Only articles authored by at least one researcher from Novo Nordisk are included in the search results. The database provides easy access to tables of contents, abstracts, bibliographic information, and abstracts from the most recently published issues of leading scholarly journals.
Journal |
Author | Year | |
| Diabetes Obesity and Metabolism Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study |
Nauck M ; Frid A ; Hermansen K ; Thomsen AB ; During M ; Shah N ; Tankova T ; Mitha I ; Matthews DR | 2013 | |
| Diabetes Obesity and Metabolism Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme |
Niswender K ; Pi-Sunyer X ; Buse J ; Jensen KH ; Toft AD ; Russell-Jones D ; Zinman B | 2013 | |
| Diabetes Obesity and Metabolism Insulin aspart has a shorter duration of action than human insulin over a wide dose-range |
Nosek L ; Roggen K ; Heinemann L ; Gottschalk C ; Kaiser M ; Arnolds S ; Heise T | 2013 | |
| Diabetes Obesity and Metabolism Incretin and pancreatic hormone secretion in Caucasian non- diabetic carriers of the TCF7L2 rs7903146 risk T allele |
Faerch K ; Pilgaard K ; Knop FK ; Hansen T ; Pedersen O ; Jorgensen T ; Holst JJ | 2013 | |
| Diabetes Obesity and Metabolism Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials |
Ratner RE ; Gough SCL ; Mathieu C ; Del Prato S ; Bode B ; Mersebach H ; Endahl L ; Zinman B | 2013 | |
| Diabetes Research and Clinical Practice Diabetes Attitudes Wishes and Needs 2 (DAWN2): A multinational, multi-stakeholder study of psychosocial issues in diabetes and person-centred diabetes care |
Peyrot M ; Burns KK ; Davies M ; Forbes A ; Hermanns N ; Holt R ; Kalra S ; Nicolucci A ; Pouwer F ; Wens J ; Willaing I ; Skovlund SE | 2013 | |
| Diabetic Medicine Urinary sulphate excretion and progression of diabetic nephropathy in Type1 diabetes |
Andresdottir G ; Bakker SJL ; Hansen HP ; Parving HH ; Rossing P | 2013 | |
| Diabetic Medicine Psychometric and screening properties of the WHO-5 well-being index in adult outpatients with Type 1 or Type 2 diabetes mellitus |
Hajos TRS ; Pouwer F ; Skovlund SE ; Den Oudsten BL ; Geelhoed-Duijvestijn PHLM ; Tack CJ ; Snoek FJ | 2013 | |
| Diabetic Medicine Insulin analogues in children with Type 1 diabetes: a 52-week randomized clinical trial |
Thalange N ; Bereket A ; Larsen J ; Hiort LC ; Peterkova V | 2013 | |
| Diabetic Medicine Insulin degludec improves health-related quality of life (SF- 36 (R)) compared with insulin glargine in people with Type 2 diabetes starting on basal insulin: a meta-analysis of phase 3a trials |
Freemantle N ; Meneghini L ; Christensen T ; Wolden ML ; Jendle J ; Ratner R | 2013 | |
| Diabetic Medicine Recall of HbA(1c) and self-management behaviours, patient activation, perception of care and diabetes distress in Type2 diabetes |
Willaing I ; Rogvi SA ; Bogelund M ; Almdal T ; Schiotz M | 2013 | |
| Diabetic Medicine Risk scores for diabetes and impaired glycaemia in the Middle East and North Africa |
Handlos LN ; Witte DR ; Almdal TP ; Nielsen LB ; Badawi SE ; Sheikh ARA ; Belhadj M ; Nadir D ; Zinai S ; Vistisen D | 2013 | |
| Diabetologia Growth arrest specific protein (GAS) 6: a role in the regulation of proliferation and functional capacity of the perinatal rat beta cell |
Haase TN ; Rasmussen M ; Jaksch CAM ; Gaarn LW ; Petersen CK ; Billestrup N ; Nielsen JH | 2013 | |
| Diabetologia Reassessment of the putative role of BLK-p.A71T loss-of- function mutation in MODY and type 2 diabetes |
Bonnefond A ; Yengo L ; Philippe J ; Dechaume A ; Ezzidi I ; Vaillant E ; Gjesing AP ; Andersson EA ; Czernichow S ; Hercberg S ; Hadjadj S ; Charpentier G ; Lantieri O ; Balkau B ; Marre M | 2013 | |
| Diabetologia A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus |
Roscioni SS ; de Zeeuw D ; Hellemons ME ; Mischak H ; Zurbig P ; Bakker SJL ; Gansevoort RT ; Reinhard H ; Persson F ; Lajer M ; Rossing P ; Heerspink HJL | 2013 | |
| Diabetologia Effect of time of day and fasting duration on measures of glycaemia: analysis from the Whitehall II Study |
Hulman A ; Faerch K ; Vistisen D ; Karsai J ; Nyari TA ; Tabak AG ; Brunner EJ ; Kivimaki M ; Witte DR | 2013 | |
| Diabetologia Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes |
Albrechtsen A ; Grarup N ; Li Y ; Sparso T ; Tian G ; Cao H ; Jiang T ; Kim SY ; Korneliussen T ; Li Q ; Nie C ; Wu R ; Skotte L ; Morris AP ; Ladenvall C | 2013 | |
| Diabetologia Common variant in the HMGA2 gene increases susceptibility to nephropathy in patients with type 2 diabetes |
Alkayyali S ; Lajer M ; Deshmukh H ; Ahlqvist E ; Colhoun H ; Isomaa B ; Rossing P ; Groop L ; Lyssenko V | 2013 | |
| Diabetologia Effects of 12 weeks' treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled study |
Hove KD ; Brons C ; Faerch K ; Lund SS ; Petersen JS ; Karlsen AE ; Rossing P ; Rehfeld JF ; Vaag A | 2013 | |
| Diabetologia Impact of early detection and treatment of diabetes on the 6- year prevalence of cardiac autonomic neuropathy in people with screen-detected diabetes: ADDITION-Denmark, a cluster- randomised study |
Charles M ; Fleischer J ; Witte DR ; Ejskjaer N ; Borch-Johnsen K ; Lauritzen T ; Sandbaek A | 2013 | |
 |
|||
Previous
